Blue Jet Healthcare Achieves Significant Milestones in Green Energy Adoption and Water Stewardship

Blue Jet Healthcare Achieves Significant Milestones in Green Energy Adoption and Water Stewardship​

Blue Jet Healthcare Limited has completed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, showcasing strong performance across operational efficiency, environmental stewardship, and workforce development. The report details the company's commitment to ESG principles while expanding its market reach in the pharmaceutical and FMCG sectors.

The company is a major manufacturer of chemical products, pharmaceuticals, medicinal chemical, and botanical products. With 100% of its business dedicated to manufacturing, Blue Jet Healthcare leverages its extensive operational footprint across 8 locations and 1 corporate office. The company serves markets spanning 7 states nationally and over 50 countries internationally. Exports constitute approximately 90% of the entity's total turnover.

The core product offerings for the entity include Pharmaceutical Intermediaries and Active Pharmaceuticals Ingredients (APIs) at 33%, Contrast Media at 53%, and High Intensity Sweeteners at 14%. The company maintains a robust commitment to responsible manufacturing practices, operating in line with ISO 9001:2015, FSSC 22000, WHO-GMP, and applicable regulatory requirements.

Environmental and Operational Focus​

A key highlight of the FY 2025-26 report is Blue Jet Healthcare’s accelerating transition toward clean energy and advanced resource management. The company successfully increased renewable energy consumption from 26,321.38 GJ in FY 2024-25 to 40,836.79 GJ in the current financial year, driven by the commissioning of a 5.625 MW solar power plant and a 3.2 MW wind power project. Collectively, these initiatives mean that approximately 57% of the company's total energy requirements are currently met through renewable sources.

Operational sustainability is heavily focused on water conservation and waste management:

• Water Stewardship: Blue Jet Healthcare has implemented a Zero Liquid Discharge (ZLD) system at its facility. This comprehensive approach utilizes Effluent Treatment Plants (ETP), Multiple Effect Evaporators (MEE), and Reverse Osmosis (RO) facilities to ensure that effluent is treated, reclaimed, and reused within operations.
• Waste Management: Total waste generated across all establishments stood at 1050.33 metric tons in FY2025-26, a reduction from the 2466.23 MT reported in FY2024-25. Key managed waste streams include Process Residue (29.283 MT), ETP Sludge (501.955 MT), and MEE Sludge (59.334 MT). Selected hazardous waste streams are sent to approved pre-processors and co-processors for resource recovery.

Workforce and Stakeholder Management​

The company maintains a workforce of 508 employees and 73 workers. The staff composition shows that nearly 86% of the total workforce is male, with 13.78% of all employees being female. This highlights management’s commitment to employee well-being through comprehensive benefits.


The company also manages its supply chain diligently, reporting that 100% of value chain partners were assessed on key human rights measures, including assessments related to Sexual Harassment, Discrimination at the Workplace, Child Labour, and Forced Labour/Involuntary Labour. The company’s commitment extends to ensuring all contracts incorporate fundamental human rights principles.

Governance and Compliance Highlights​

Blue Jet Healthcare operates under a structured framework for governance and ethical conduct, underpinned by a comprehensive Code of Conduct and an Anti-Bribery and Anti-Corruption (ABAC) Policy.

The management structure includes designated oversight:

• CEO/Senior Official: Mr. Karuppannan Ganesh is responsible for implementing and overseeing the Business Responsibility Policy.
• Quality Assurance: The BRSR Core KPIs were subjected to reasonable assurance by TUV India Private Limited, validating the accuracy and reliability of the reported information.

The company’s commitment to safe working conditions was underscored by zero Lost Time Injury Frequency Rate (LTIFR) for both employees and workers in FY2025-26. Furthermore, the company demonstrated a focus on employee support, reporting that 97.83% of permanent employees were covered by Provident Fund (PF).

The BRSR reflects Blue Jet Healthcare's sustained dedication to operational excellence, ethical sourcing, and contributing positively to environmental goals across its domestic and international markets.

BLUEJET Stock Price Movement​

Blue Jet Healthcare Limited stock is gaining ground at 2:22 PM, trading at ₹608.5 after climbing ₹15.30 or 2.58%. The equity sees high momentum in live market activity, with 1.18 million shares changing hands during the session.